Ameriprise Financial Inc Revance Therapeutics, Inc. Transaction History
Ameriprise Financial Inc
- $358 Billion
- Q1 2024
A detailed history of Ameriprise Financial Inc transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 169,911 shares of RVNC stock, worth $436,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,911
Previous 178,103
4.6%
Holding current value
$436,671
Previous $1.57 Million
46.65%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding RVNC
# of Institutions
214Shares Held
83.4MCall Options Held
656KPut Options Held
424K-
Capital World Investors Los Angeles, CA13.9MShares$35.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.31MShares$18.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.28MShares$16.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$13.9 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.25MShares$13.5 Million3.02% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...